Announced Thu, 18 Jun · 11:05 IST
Promoter Investcorp files annual no-encumbrance declaration for FY26
Compliance View source PDF
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹734.95
prior close
₹724.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.0-0.2+0.3-0.1-1.2-5.4-7.5-9.5-7.5-11.3-14.2——
Up moveDown movePending
AI summary
Investcorp Private Equity Fund II, a promoter of Nephrocare Health Services (NEPHROPLUS), has filed an annual declaration under SEBI Regulation 31(4) confirming that no new encumbrance was created on the company's shares during the financial year ending March 31, 2026, other than those already disclosed. This is a routine annual compliance filing required from promoters and persons acting in concert.
Likely market impact
Routine annual regulatory filing by promoter confirming no new pledge or encumbrance on shares. Neutral for shareholders.